研究领域肿瘤 细胞生物 神经生物学
抗体来源Mouse
克隆类型Monoclonal
克 隆 号7D8
交叉反应Human, Mouse, Rat,
产品应用WB=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 (石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理论分子量49kDa
细胞定位细胞浆
性 状Liquid
浓 度1mg/ml
免 疫 原Recombinant mouse GFAP full length
亚 型IgG
纯化方法affinity purified by Protein G
缓 冲 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMedPubMed
产品介绍This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Function:
GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.
Subunit:
Interacts with SYNM. Isoform 3 interacts with PSEN1 (via N-terminus).
Subcellular Location:
Cytoplasm. Note=Associated with intermediate filaments.
Tissue Specificity:
Expressed in cells lacking fibronectin.
Post-translational modifications:
Phosphorylated by PKN1.
DISEASE:
Defects in GFAP are a cause of Alexander disease (ALEXD) [MIM:203450]. Alexander disease is a rare disorder of the central nervous system. It is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of Rosenthal fibers which are cytoplasmic inclusions in astrocytes. The most common form affects infants and young children, and is characterized by progressive failure of central myelination, usually leading to death usually within the first decade. Infants with Alexander disease develop a leukoencephalopathy with macrocephaly, seizures, and psychomotor retardation. Patients with juvenile or adult forms typically experience ataxia, bulbar signs and spasticity, and a more slowly progressive course.
Similarity:
Belongs to the intermediate filament family.
SWISS:
P14136
Gene ID:
2670